School of Chinese Medicine, HKBU

🚀 Join us at 𝐭𝐡𝐞 4𝐭𝐡 𝐀𝐬𝐢𝐚 𝐄𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐈𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐬 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 (𝐀𝐄𝐈𝐈) to explore SCM’s pioneering projects at the HKBU booth! 📅 Date: 5 - 6 Dec 2024 📍 Venue: HKCEC, Hall 1D-E (Entrepreneur Day) 💡 𝐂𝐨𝐦𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐓𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐑𝐡𝐞𝐮𝐦𝐚𝐭𝐨𝐢𝐝 𝐀𝐫𝐭𝐡𝐫𝐢𝐭𝐢𝐬 (𝐏𝐈: 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐨𝐫 𝐘𝐮 𝐙𝐡𝐢𝐥𝐢𝐧𝐠) This invention combines luteolin and scoparone to provide effective anti-arthritic effects with reduced side effects, offering a safer alternative for patients. 💡 𝐓𝐫𝐲𝐩𝐭𝐨𝐩𝐡𝐚𝐧 𝐒𝐮𝐥𝐟𝐨𝐧𝐚𝐭𝐞: 𝐀 𝐍𝐞𝐰 𝐂𝐡𝐞𝐦𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐫 𝐟𝐨𝐫 𝐀𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐚𝐧𝐝 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 𝐈𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐒𝐮𝐥𝐟𝐮𝐫-𝐭𝐫𝐞𝐚𝐭𝐞𝐝 𝐅𝐨𝐨𝐝 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬 (𝐏𝐈: 𝐃𝐫. 𝐗𝐮 𝐉𝐮𝐧) This innovative method uses tryptophan sulfonate as a specific marker to identify sulfur-treated foods, ensuring enhanced accuracy and environmental sustainability in food safety inspections. We aim to make a significant impact on healthcare and food safety. See you there! Hong Kong Baptist University Knowledge Transfer Office (KTO), HKBU #HKBU #SCM #HKBUSCM #SchoolofChineseMedicine #Technologytransfer #Innovation #Inventions #AEII2024 #RheumatoidArthritis #FoodSafety #EntrepreneurDay #HKBUResearch

🌱 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐍𝐞𝐰 𝐅𝐨𝐫𝐜𝐞: 𝐏𝐡𝐃 𝐒𝐭𝐮𝐝𝐞𝐧𝐭 𝐌𝐫. 𝐂𝐇𝐄𝐍 𝐁𝐚𝐢𝐬𝐞𝐧 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐬 𝐕𝐢𝐧𝐜𝐞𝐧𝐭 & 𝐋𝐢𝐥𝐲 𝐖𝐨𝐨 𝐅𝐞𝐥𝐥𝐨𝐰𝐬𝐡𝐢𝐩 PhD student CHEN Baisen, Parson has been awarded the “2023-24 Vincent & Lily Woo Fellowship”. Funded by the Vincent & Lily Woo Foundation, the Fellowship aims to encourage PhD students in the Greater Bay Area to undertake Chinese medicine research projects, nurturing potential talents in the development of Chinese medicine. It supports two outstanding students each year, with a total of HKD 150,000 over three years. Parson thanks the Foundation for its generous support and he is aspired to make a positive impact on the community through his research. Congratulations to Parson! The School is dedicated to cultivating and nurturing outstanding talents in Chinese medicine within the Greater Bay Area, thereby contributing to the advancement of industry. #HKBU #SCM #SchoolofChineseMedicine #ChineseMedicineResearch #HKBUResearch #ResearchNewForce #Youngresearcher #PhD

𝐇𝐊𝐁𝐔 𝐜𝐨𝐧𝐟𝐞𝐫𝐬 𝐃𝐨𝐜𝐭𝐨𝐫 𝐨𝐟 𝐒𝐜𝐢𝐞𝐧𝐜𝐞, 𝐡𝐨𝐧𝐨𝐫𝐢𝐬 𝐜𝐚𝐮𝐬𝐚 𝐮𝐩𝐨𝐧 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐨𝐫 𝐓𝐚𝐧 𝐖𝐞𝐢𝐡𝐨𝐧𝐠 👨🎓 Hong Kong Baptist University (HKBU) held the Honorary Doctoral Degree Conferment Ceremony on 18 November and conferred the Doctor of Science, honoris causa, upon Professor Tan Weihong, nominated by the School of Chinese Medicine, in recognition of his pioneering contributions to aptamer research and applications, bioanalysis, and molecular medicine. This year, a total of five distinguished individuals have been conferred honorary doctoral degrees. The Ceremony was presided over by Dr. Clement Chen, Chairman of the Council and the Court of HKBU. On the same day, Professor Tan Weihong delivered a distinguished lecture organised by SCM. Titled “Aptomics Lead to Multiomics”, the lecture showcased Professor Tan’s research experience and insights in the field of molecular medicine. He emphasised three core elements of success: Intelligence Quotient, Emotional Quotient and Happiness Quotient, and encouraged researchers to adopt a positive and proactive attitude in their work to enhance efficiency. Over 100 attendees from SCM and the Faculty of Science were deeply inspired. The School extends its heartfelt congratulations to Professor Tan on his conferment of the Doctor of Science, honoris causa, and looks forward to further collaboration with him in the realm of molecular medicine. For more information on the five honorary doctoral degree recipients: https://lnkd.in/euMgui29 #HKBU #HKBUSCM #SCM #SchoolofChineseMedicine #MolecularMedicine #aptamer #bioanalysis #HonoraryDoctoralDegree #HKBUResearch

🌱𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐍𝐞𝐰 𝐅𝐨𝐫𝐜𝐞: 𝐏𝐡𝐃 𝐬𝐭𝐮𝐝𝐞𝐧𝐭 𝐇𝐮𝐚𝐧𝐠 𝐂𝐡𝐮𝐧𝐡𝐮𝐚 𝐜𝐥𝐢𝐧𝐜𝐡𝐞𝐬 𝐂𝐡𝐚𝐦𝐩𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 2024 𝐊𝐰𝐨𝐤 𝐂𝐡𝐮𝐧𝐠 𝐁𝐨 𝐅𝐮𝐧 𝐏𝐡𝐃 𝐒𝐭𝐮𝐝𝐞𝐧𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞 𝐀𝐰𝐚𝐫𝐝 🏆 Big applause to our PhD student Huang Chunhua, who has been awarded the championship in the 2024 Kwok Chung Bo Fun PhD Student Research Excellence Awards! An award ceremony attended by Mr. Raymond Kwok, representative of the Kwok Chung Bo Fun Charitable Fund, Professor Alexander Wai, President and Vice-Chancellor of HKBU, distinguished guests, staff and students, was held to recognise the outstanding research achievements of our young researchers.     After the ceremony, Chunhua shared with the audience the research project titled “Chinese Herbal Formulation CDD-2103 Alleviates Ulcerative Colitis via Immunomodulation” and his significant contributions under the supervision of Professor zhaoxiang Bian and Dr. Tan Hor Yue. This novel formulation has received approval from the National Medical Products Administration of China to conduct Phase II clinical trials. The research team plans to initiate these trials in mainland China next year to verify the drug’s effectiveness and safety for maintaining remission in ulcerative colitis. The findings have been published in 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘈𝘥𝘷𝘢𝘯𝘤𝘦𝘥 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩. At SCM, we provide diverse research opportunities and are dedicated to nurturing young talent. Join us: https://lnkd.in/gHViEeMC

Professor Lyu Aiping, Vice-President (Research and Development) cum Acting Dean of Chinese Medicine, was recently invited by Elsevier to the #QSHigherEdSummit APAC in Macau to discuss the global impact of Traditional Chinese Medicine (TCM). He shared the latest developments in TCM research and education, his visionary outlook for TCM as a global discipline, and emphasized the importance of integrating life and data sciences into TCM treatments. Register for the HKBU x Elsevier Research Landscape Study of Traditional Chinese Medicine (TCM) report: https://lnkd.in/g3yTYDhb Interested in TCM research? Stay tuned with us for more exciting updates! #HKBU #HKBUSCM #SchoolofChineseMedicine #HKBUResearch #ChineseMedicineResearch

🎊 𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐧𝐠 𝐒𝐮𝐜𝐜𝐞𝐬𝐬: 𝐁𝐎𝐂–𝐇𝐊𝐁𝐔 𝐂𝐡𝐢𝐧𝐞𝐬𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲 𝐒𝐭𝐫𝐨𝐤𝐞 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑𝐞𝐡𝐚𝐛𝐢𝐥𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐒𝐜𝐡𝐞𝐦𝐞 The BOC-HKBU Chinese Medicine Community Stroke Prevention and Rehabilitation Scheme, launched by the School of Chinese Medicine (SCM) and the Hong Kong Sheng Kung Hui Welfare Council in 2020, has benefited nearly 95,000 individuals over the past four years! Supported by a generous donation from the Bank of China (Hong Kong), the Scheme has provided over 31,000 treatment sessions to elderly stroke patients and those at medium to high risk of stroke. An exhibition was held from 26 to 27 October to showcase the Scheme’s remarkable results. We were honored to have officiating guests, including Dr. Chung Chi-ho, Commissioner for Chinese Medicine Development of the Chinese Medicine Unit of the Health Bureau; Mr. Peter Ng, Assistant General Manager of the Public Sector and Institutional Business Department of the Bank of China (Hong Kong); and Professor Chan Wing-kwong, member of the Legislative Council; Ms. Christine Chow, Vice-President (Administration) and Secretary of HKBU; Professor Li Min, Executive Associate Dean of the School of Chinese Medicine at HKBU; and Ms. Wong Chui-yan, Assistant Director of the Hong Kong Sheng Kung Hui Welfare Council. Under the Scheme, nearly 470 stroke recovery patients received more than 28,000 treatment sessions, including acupuncture, massage therapy, and Chinese medicine. This led to significant improvements in their self-care abilities and cognitive functions, resulting in an enhancement of life quality. The Scheme also provided free Chinese herbal tea treatment for stroke prevention to over 1,000 high-risk individuals. Data shows that body constitutions of these participants improved after four months of treatment, effectively reducing their risk of stroke. Furthermore, around 138 elders were trained to serve as “Senior Ambassadors for Stroke Prevention” actively promoting awareness through over 200 talks and an informative website. SCM will continue to support and initiate various community Chinese medicine services, making greater contributions to public health. #HKBU #HKBUSCM #SCM #SchoolofChineseMedicine #Stroke

🏆 𝐀𝐧𝐨𝐭𝐡𝐞𝐫 𝐚𝐜𝐜𝐨𝐥𝐚𝐝𝐞: 𝐉𝐨𝐢𝐧𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐭𝐞𝐚𝐦 𝐟𝐫𝐨𝐦 𝐒𝐂𝐌 𝐚𝐧𝐝 𝐒𝐡𝐚𝐧𝐠𝐡𝐚𝐢 𝐒𝐢𝐱𝐭𝐡 𝐏𝐞𝐨𝐩𝐥𝐞'𝐬 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐬 “𝐅𝐢𝐫𝐬𝐭 𝐏𝐫𝐢𝐳𝐞 𝐨𝐟 𝐒𝐡𝐚𝐧𝐠𝐡𝐚𝐢 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐚𝐧𝐝 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬 𝐀𝐰𝐚𝐫𝐝” 🎉 Hooray! Professor Zhang Ge, Associate Dean (Research) of Chinese Medicine and Director of the Technology Development Division, leading the Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases of HKBU, together with experts from Shanghai Sixth People's Hospital under the Shanghai Jiao Tong University School of Medicine, have been awarded the First Prize of the Shanghai Science and Technology Progress Award for their project titled “𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦𝐬 𝐚𝐧𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐟 𝐇𝐞𝐫𝐞𝐝𝐢𝐭𝐚𝐫𝐲 𝐁𝐨𝐧𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬”. This prestigious award is established by the Shanghai Municipal Government, aiming to encourage innovative research and foster a supportive environment for scientific advancement. The project has already won the First Prize of Shanghai Medical Science and Technology Award earlier this year. Congratulations again to Professor Zhang and his team! SCM is dedicated to fostering a dynamic environment that supports technology transfer to create real-world impacts for society. More about Professor Ge Zhang: https://lnkd.in/gkFwFcSy HKBU Research Office #HKBU #HKBUSCM #SCM #SchoolofChineseMedicine #HKBUResearch #drugdiscovery #HereditaryBoneDiseses

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞: 11 𝐒𝐂𝐌 𝐒𝐜𝐡𝐨𝐥𝐚𝐫𝐬 𝐑𝐚𝐧𝐤𝐞𝐝 𝐀𝐦𝐨𝐧𝐠 𝐭𝐡𝐞 𝐖𝐨𝐫𝐥𝐝’𝐬 𝐓𝐨𝐩 2% 𝐌𝐨𝐬𝐭-𝐜𝐢𝐭𝐞𝐝 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭𝐬 🎉 We are excited to announce that 11 SCM scholars have been recognized among the world’s top 2% most-cited scientists in 2024, as reported by Stanford University. This remarkable achievement underscores the continuous dedication of our scholars and highlights the School's research strengths and significant global impact. At SCM, we remain dedicated to nurturing a vibrant research environment that fosters innovation and creates a positive and lasting impact on the world. Congratulations to the world’s top 2% most-cited scientists from SCM: 🔸 Professor Bian Zhaoxiang 🔸Professor Chen Hubiao 🔸Professor Han Quanbin, Simon 🔸Dr. Kwan Hiu-Yee, Anna 🔸Professor Li Min 🔸Professor Lyu Aiping 🔸Dr. Tan Hor Yue 🔸Dr. Yi Tao 🔸Professor Zhang Ge 🔸Professor Zhang Hongjie 🔸Professor Zhao Zhongzhen   HKBU Research Office #HKBU #SCM #SchoolofChineseMedicine #HKBUSCM #HKBUResearch #ResearchExcellence #ChineseMedicine #StanfordUniversity #TopScientists #Innovation

💊𝐒𝐂𝐌’𝐬 6𝐭𝐡 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐮𝐦𝐦𝐢𝐭 𝐨𝐧 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐂𝐨𝐧𝐜𝐥𝐮𝐝𝐞𝐬 𝐒𝐮𝐜𝐜𝐞𝐬𝐬𝐟𝐮𝐥𝐥𝐲! On 26 October, SCM hosted the 6th International Summit on Innovative Drug Discovery on campus. The Summit gathered distinguished scholars and pioneers from the drug discovery and pharmaceutical fields, discussing the trends and challenges of innovative drug development, and sharing personal experience of their translational research in drug discovery. In his welcoming address, Professor Alex Wai, President and Vice-Chancellor of HKBU, emphasized the University’s commitment to the promotion of innovative research and translation of research outcome for offering better health solutions to the society, and shared the latest developments of the University's Chinese medicine research teams in new drug discovery and clinical trials. Also speaking at the Ceremony, Professor Lyu Aiping, Vice-President (Research and Development) cum Acting Dean of Chinese Medicine, acknowledged the valuable contribution of Chinese medicine to modern drug innovation and stressed the importance of transdisciplinary collaboration in accelerating future medical development. The Summit attracted over 400 attendees from industry and academia, offering a vital platform for academic exchange and transdisciplinary collaboration for the advancement of new drug research development. Hong Kong Baptist University #HKBU #HKBUSCM #SCM #SchoolofChineseMedicine #DrugDiscovery #HKBUResearch #HealthCare #ResearchCollaboration #ChineseMedicine

𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐂𝐨𝐧𝐭𝐫𝐨𝐥 𝐢𝐧 𝐂𝐡𝐢𝐧𝐞𝐬𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬: 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 2024 𝐇𝐊 𝐒𝐮𝐦𝐦𝐢𝐭  The School of Chinese Medicine (SCM) proudly hosted the 2024 𝐇𝐊 𝐒𝐮𝐦𝐦𝐢𝐭 𝐨𝐧 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐂𝐨𝐧𝐭𝐫𝐨𝐥 𝐨𝐟 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐂𝐡𝐢𝐧𝐞𝐬𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 in collaboration with the HK Authentication Centre of Valuable Chinese Medicines at Hong Kong Baptist University (HKBU) on 19 October. We were thrilled to welcome over 100 participants from both the Chinese medicine industry and academia. This year's Summit focused on the critical theme of quality control for valuable Chinese medicines, addressing key topics such as herbal medicine identification and the sustainable development of herbal resources. Attendees benefited from the four insightful speeches that delved into essential research and quality evaluation: 🔸The application of classical and high-throughput DNA sequencing for the authentication of herbal materials 🔸Research on Quality Assurance Systems for Cicadae Periostracum Resources 🔸The anti-colitis effects of Astragali polysaccharide RAP 🔸A chemical marker for screening sulfur-treated herbal medicines Our scholars engaged in meaningful discussions with participants, fostering a collaborative environment that bridges industry and academia. Thank you for making this event a success! Together, we are enhancing public confidence in the quality of valuable Chinese medicines. #HKBU #HKBUSCM #SCM #ChineseMedicine #QualityControl #HKBUResearch #Collaboration #Sustainability